Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PTIX |
---|---|---|
10:48 ET | 250 | 0.7008 |
11:51 ET | 2000 | 0.725351 |
12:59 ET | 886 | 0.734251 |
01:10 ET | 100 | 0.7007 |
02:20 ET | 1262 | 0.7028 |
02:24 ET | 278 | 0.7049 |
03:14 ET | 195 | 0.7013 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Protagenic Therapeutics Inc | 3.3M | -0.5x | --- |
CNS Pharmaceuticals Inc | 3.2M | 0.0x | --- |
Zyversa Therapeutics Inc | 3.2M | 0.0x | --- |
GB Sciences Inc | 3.2M | -0.8x | --- |
Alzamend Neuro Inc | 3.1M | -0.2x | --- |
Aptevo Therapeutics Inc | 3.1M | 0.0x | --- |
Protagenic Therapeutics, Inc. is a biopharmaceutical company specializing in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress responses. Its lead compound is a 41-amino-acid synthetic peptide, which focuses on treating various neuro-psychiatric conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD). It operates with a novel mechanism, mirroring the active part of the natural brain hormone TCAP, thereby reducing circulating cortisol levels. In addition, it has a portfolio of earlier stage neuropeptides targeting the TCAP pathway that are in preclinical evaluation. The initial dosage form is intended as a subcutaneous injection but is also amenable to other routes of administration including sublingually or intra-nasally.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 4.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.03 |
EPS | $-1.37 |
Book Value | $0.83 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.